Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity.

Kormann, Michael S D; Dewerth, Alexander; Eichner, Felizitas; Baskaran, Praveen; Hector, Andreas; Regamey, Nicolas; Hartl, Dominik; Handgretinger, Rupert; Antony, Justin S (2017). Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity. PLoS ONE, 12(8), e0183526. Public Library of Science 10.1371/journal.pone.0183526

Preview

Text 28846703.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (4MB) | Preview

Cystic Fibrosis (CF) is the most common monogenic disease among people of Western European descent and caused by mutations in the CFTR gene. However, the disease severity is immensely variable even among patients with similar CFTR mutations due to the possible effect of 'modifier genes'. To identify genetic modifiers, we applied RNA-seq based transcriptomic analyses in CF patients with a mild and severe lung phenotype. Global gene expression and enrichment analyses revealed that genes of the type I interferon response and ribosomal stalk proteins are potential modifiers of CF related lung dysfunction. The results provide a new set of CF modifier genes with possible implications as new therapeutic targets for the treatment of CF.

Interest & Impact

Downloads

400 since deposited on 31 Jan 2018
28 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item